Accelerating global chemical product innovation and development

Scientific and regulatory support to market and sustain your products in any jurisdiction.

Competitive Advantage

Acta is a global scientific and regulatory consulting firm that assists companies that make and use chemicals with strategic commercialization planning and complex product registration and compliance matters.

We partner with our clients to help them get products quickly and efficiently to market — in any country or locale — and keep them there when challenged by a new regulatory regime, issue, or set of rules.

More About Us

Knowledge & Insights

  March 26, 2024
Memoranda
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  April 23, 2024
Memoranda
EPA Designates PFOA and PFOS as CERCLA Hazardous Substances, Releases CERCLA Enforcement Discretion Policy

On April 19, 2024, the U.S. Environmental Protection Agency (EPA) announced a final rule that will designate perfluorooctanoic acid (PFOA),...

  April 22, 2024
Memoranda
EPA Issues Fourth TSCA Test Order for PFAS

The U.S. Environmental Protection Agency (EPA) announced on March 25, 2024, that it has issued the fourth Toxic Substances Control Act (TSCA) test...

  April 12, 2024
Global Regulatory Updates
Global Regulatory Update for April 2024

WEBINAR – Registration Is Open For “Harmonizing TSCA Consent Orders with OSHA HCS 2012”: Register now to join The Acta Group (Acta®) and...

  April 9, 2024
Memoranda
FDA Reports That No Asbestos Was Detected in Its 2023 Testing of Talc-Containing Cosmetic Products

The U.S. Food and Drug Administration (FDA) announced on April 5, 2024, the results of its 2023 sampling assignment, testing talc-containing cosmetic...

  April 5, 2024
Memoranda
EPA Proposes to Require Submission of Health and Safety Studies for 16 Chemicals Being Considered for TSCA Risk Evaluation

The U.S. Environmental Protection Agency (EPA) published on March 26, 2024, a proposed rule requiring manufacturers (including importers) of 16...

  March 28, 2024
Memoranda
EPA Bans Ongoing Uses of Asbestos

On March 28, 2024, the U.S. Environmental Protection Agency (EPA) issued a final rule under the Toxic Substances Control Act (TSCA) to address to the...

Seminars & Webinars

  April 12, 2024
Seminars & Webinars
Sponsor’s Role in Regulatory Testing, June 12, 2024, 11:00 a.m. – 12:00 p.m. (EDT), via webinar

Register now to join Bergeson & Campbell, P.C. (B&C®) and The Acta Group (Acta®) for “Sponsor’s Role in Regulatory Testing —...

  March 21, 2024
Seminars & Webinars
TSCA Reform – 8 Years Later, June 26, 2024, George Washington University Milken Institute School of Public Health, Washington, D.C., and via livestream

Save the date to join Bergeson & Campbell, P.C. (B&C®), the Environmental Law Institute (ELI), and the George Washington University...

  March 21, 2024
Seminars & Webinars
Product Sustainability USA 2024, June 26-27, 2024, Boston, MA

Chemical Watch presents Product Sustainability USA, a two-day conference focusing on the most recent developments around sustainability for the...

With offices in the U.S., UK, and Europe, and partners and agents in China, South Korea, Turkey, Mexico, and more, Acta offers expertise with regulatory programs and chemical product approvals in North America, Europe, South and Central America, and Asia.

Our Firms

our people

Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, seven Ph.D.’s. Government affairs and regulatory specialists including nine high-level EPA alumni. Business strategists with decades of experience directing worldwide regulatory compliance.

Acta consultants manage products from concept to approval, delivering skills and experience with specific product areas in government and industry.

Our three affiliated firms -- B&C, Acta, and BCCM -- provide a full range of global support for the commercialization of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.